JapanStake
Pharmaceutical · Fiscal year end Mar 31

Shionogi & Co.,Ltd.

4507

塩野義製薬株式会社

FIGI BBG000BJQ7X54507.T4507 JPCorp. no. 9120001077430

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-07

For the first half of the fiscal year to 2026-03: Revenue ¥213 billion (-0.5% YoY), Profit before tax ¥98.4 billion (+4.9% YoY), Net income ¥83.5 billion (+0.5% YoY).

This periodYear on year
Revenue¥213.0bn-0.5%
Profit before tax¥98.4bn+4.9%
Net profit to owners¥83.5bn+0.5%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4507/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2026-03-31
Revenue
¥499.7bn
Net income
¥205.2bn
ROE
13.5%
Equity ratio
65.4%
Dividend / share
¥71
Employees
6,223
Revenue · ¥bn
FY2022: ¥335.1bn 335 FY2022FY2023: ¥426.7bn 427 FY2023FY2024: ¥410.1bn 410 FY2024FY2025: ¥438.3bn 438 FY2025FY2026: ¥499.7bn 500 FY2026
Net income · ¥bn
FY2022: ¥114.2bn 114 FY2022FY2023: ¥185.0bn 185 FY2023FY2024: ¥162.0bn 162 FY2024FY2025: ¥170.4bn 170 FY2025FY2026: ¥205.2bn 205 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥499.7bn¥205.2bn¥2,576.9bn¥1,685.2bn13.5%¥241.11¥213.6bn
2025-03-31¥438.3bn¥170.4bn¥1,535.3bn¥1,361.9bn13.1%¥200.36¥195.5bn
2024-03-31¥410.1bn¥162.0bn¥1,416.9bn¥1,235.3bn13.9%¥186.17¥154.3bn
2023-03-31¥426.7bn¥185.0bn¥1,311.8bn¥1,100.0bn17.8%¥207.1¥177.9bn
2022-03-31¥335.1bn¥114.2bn¥1,150.6bn¥975.7bn12.5%¥126.25¥102.1bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %13.573.8
Ordinary margin0.478199.4
Equity ratio, %65.466.7
Revenue growth0.140178.4
Net income growth0.203756.5
Operating cash flow / assets0.082963.1
Policy-uncertainty measure1.54 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 4 Fiscal & tax 1 Regulation 4 Politics & geopolitics 4
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 1 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 5.9% held by other listed companies.

Results wording balance: +0.75. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4507/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-19: see filing 上記の評価の結果、当連結会計年度末日時点において、当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-24 · 剰余金の処分の件 · passed. /v1/companies/4507/voting

Ownership changes

All companies →

5% filings

Large shareholding reports on 4507
FiledFilerStakeChangeStated purpose
2026-05-11Wellington Management Company LLP5.23%——
2025-09-19Sumitomo Mitsui Trust Bank,Limited6.36%−0.46pt—
2025-01-07BlackRock Japan Co., Ltd.7.23%+1.02ptpure investment
2024-04-03BlackRock Japan Co., Ltd.6.21%−1.12ptpure investment
2023-07-05BlackRock Japan Co., Ltd.7.33%+1.23ptpure investment
2023-06-21Sumitomo Mitsui Trust Bank,Limited6.82%−0.39pt—
2023-06-21Nomura Securities Co.,Ltd.6.09%−1.05pt—
2022-12-19Mitsubishi UFJ Financial Group, Inc.4.03%−1.05ptpure investment
2022-12-07Capital Research and Management Company4.81%−1.84ptpure investment
2022-10-07Capital Research and Management Company6.65%+0.12ptpure investment

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
15 issues
Book value
¥47.4bn
Sold in the year
¥0m 2 issues
Bought in the year
— — issues
Mutual, both reports
9
Held by listed cos.
19
HoldsBook valueShares vs. prior yearMutual
Sumitomo Mitsui Financial Group, Inc. 8316¥17.3bn0.0%both reports
TOHO HOLDINGS CO.,LTD. 8129¥16.7bn0.0%both reports
KISSEI PHARMACEUTICAL CO.,LTD. 4547¥4.3bn0.0%both reports
MEDIPAL HOLDINGS CORPORATION 7459¥3.7bn0.0%both reports
StemRIM Inc. 4599¥1.4bn0.0%no
KANEKA CORPORATION 4118¥1.3bn0.0%both reports
ONO PHARMACEUTICAL CO., LTD. 4528¥0.9bn0.0%both reports
VITAL KSK HOLDINGS,INC. 3151¥0.7bn0.0%both reports
㈱ほくやく・竹山ホールディングス¥0.3bn0.0%stated
MS&AD Insurance Group Holdings, Inc. 8725¥0.3bn0.0%both reports

Held by: Sumitomo Mitsui Financial Group, Inc. 8316, Sumitomo Mitsui Financial Group, Inc. 8316, KISSEI PHARMACEUTICAL CO.,LTD. 4547, KANEKA CORPORATION 4118, TOHO HOLDINGS CO.,LTD. 8129, Tokio Marine Holdings, Inc. 8766, MS&AD Insurance Group Holdings, Inc. 8725, NAGASE & CO., LTD. 8012, MEDIPAL HOLDINGS CORPORATION 7459, TSUMUGU Holdings, Inc. 3055, Okayama Paper Industries Co.,Ltd. 3892, Senshu Ikeda Holdings,Inc. 8714 and 10 more

Purposes, all holdings and mutual flags via /v1/companies/4507/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
日本マスタートラスト信託銀行株式会社(信託口)157,523,00018.31%
株式会社日本カストディ銀行(信託口)67,193,0007.81%
住友生命保険相互会社55,812,0006.48%
STATE STREET BANK AND TRUST COMPANY 50500135,504,0004.12%
株式会社SMBC信託銀行(株式会社三井住友銀行退職給付信託口)28,455,0003.30%
日本生命保険相互会社25,227,0002.93%
JP MORGAN CHASE BANK 38578111,142,0001.29%
STATE STREET BANK AND TRUST COMPANY 5051039,733,0001.13%
株式会社三井住友銀行9,651,0001.12%
individual holder8,774,0001.02%

U.S. funds holding 4507

SEC Form N-PORT, reports to 2026-07-31

281 U.S. funds held 116,448,590 shares worth $2.09bn.

FundSharesValue% of fundAs of
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
21,427,449$387.4m1.015%2026-07-31
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
11,128,464$201.2m0.031%2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
7,363,591$125.8m0.040%2026-06-30
Harding Loevner International Equity Portfolio
HARDING LOEVNER FUNDS INC
6,137,400$111.8m0.882%2026-07-31
iShares Core MSCI EAFE ETF
iShares Trust
5,597,900$101.2m0.053%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4507
GET /v1/companies/4507/financials
GET /v1/companies/4507/details
GET /v1/companies/4507/segments
GET /v1/companies/4507/voting
GET /v1/companies/4507/tender-offers
GET /v1/companies/4507/indicators
GET /v1/companies/4507/earnings-releases
GET /v1/events?ticker=4507
GET /v1/companies/4507/trades         
GET /v1/companies/4507/cross-holdings 
GET /v1/companies/4507/brief          

Plans from $9 a month · Documentation